Business Segment Information (Tables)

6 Months Ended

Jul. 04, 2026

Summary of Net Revenues for Company's Products and Services

Revenues for the Company’s products

and

services are as

follows

for the three and six months ended July 4, 2026 and June 28, 2025 (in millions):


	Three Months Ended				Six Months Ended
	July 4, 2026		June 28, 2025		July 4, 2026		June 28, 2025
Revenues:
Instrument systems	$	455	$	308	$	831	$	571
Consumables		765		165		1,308		303
Service		425		298		773		559

Total revenues	$	1,645	$	771	$	2,912	$	1,433

Summary of Geographic Revenues Information

Revenues are attributable to geographic areas based on the region

destination. Geographic revenues information is presented below for the three and six months ended July 4, 2026 and June 28, 2025 (in millions):


	Three Months Ended
	July 4, 2026
	Analytical & Materials Sciences		Biosciences		Advanced Diagnostics		Total Revenues
Revenues:
Asia:
China	$	118	$	48	$	40	$	206
Asia Other		156		33		55		244

Total Asia		274		81		95		450
Americas:
United States		226		149		195		570
Americas Other		47		26		47		120

Total Americas		273		175		242		690
Europe		209		112		184		505

Total net revenues	$	756	$	368	$	521	$	1,645


	Three Months Ended
	June 28, 2025
	Analytical & Materials Sciences		Biosciences		Advanced Diagnostics		Total Revenues
Revenues:
Asia:
China	$	107	$	—	$	10	$	117
Asia Other		145		—		4		149

Total Asia		252		—		14		266
Americas:
United States		210		—		19		229
Americas Other		45		—		6		51

Total Americas		255		—		25		280
Europe		202		—		23		225

Total net revenues	$	709	$	—	$	62	$	771


	Six Months Ended
	July 4, 2026
	Analytical & Materials Sciences		Biosciences		Advanced Diagnostics		Total Revenues
Revenues:
Asia:
China	$	218	$	75	$	66	$	359
Asia Other		289		57		95		441

Total Asia		507		132		161		800
Americas:
United States		430		239		316		985
Americas Other		89		44		77		210

Total Americas		519		283		393		1,195
Europe		416		185		316		917

Total net revenues	$	1,442	$	600	$	870	$	2,912


	Six Months Ended
	June 28, 2025
	Analytical & Materials Sciences		Biosciences		Advanced Diagnostics		Total Revenues
Revenues:
Asia:
China	$	188	$	—	$	20	$	208
Asia Other		270		—		9		279

Total Asia		458		—		29		487
Americas:
United States		410		—		35		445
Americas Other		82		—		9		91

Total Americas		492		—		44		536
Europe		368		—		42		410

Total net revenues	$	1,318	$	—	$	115	$	1,433

Summary of Net Revenues for the Company Recognized at a Point in Time Versus Over Time

Revenues for the Company recognized at a point in time versus over time are as

follows

for the three and six months ended July 4, 2026 and June 28, 2025 (in millions):


	Three Months Ended				Six Months Ended
	July 4, 2026		June 28, 2025		July 4, 2026		June 28, 2025
Net revenues recognized at a point in time:
Instrument systems	$	455	$	308	$	831	$	571
Consumables		765		165		1,308		303
Service revenues recognized at a point in time (time & materials)		120		100		221		181

Total net revenues recognized at a point in time		1,340		573		2,360		1,055
Net revenues recognized over time:
Service and software maintenance revenues recognized over time (contracts)		305		198		552		378

Total net revenues	$	1,645	$	771	$	2,912	$	1,433

Summary of Reconciliation of Segment Operating Income

The following table includes the significant segment expenses that are regularly provided to the CODM and a reconciliation of segment operating income for the three and six months ended July 4, 2026 and June 28, 2025 (in millions):


	Three Months Ended
	July 4, 2026
	Analytical & Materials Sciences			Biosciences			Advanced Diagnostics			Total
Total revenues, net	$	756		$	368		$	521		$	1,645
Less:
Labor costs within selling and administrative and research and development expenses		(147	)		(62	)		(84	)		(293	)
Material purchases		(123	)		(54	)		(59	)		(236	)
Labor costs within product and service cost of revenues		(71	)		(46	)		(85	)		(202	)
Other segment expenses		(149	)		(80	)		(174	)		(403	)
Corporate and other expenses:
Corporate expenses											(173	)
Purchased intangibles amortization and purchase accounting fair value step-up expenses											(399	)
Stock-based compensation											(25	)

Total operating income	$	266		$	126		$	119		$	(86	)

Operating income %		35.2	%		34.2	%		22.8	%		(5.2	%)


	Three Months Ended June 28, 2025
	Analytical & Materials Sciences			Biosciences		Advanced Diagnostics			Total
Total revenues, net	$	709		$	—	$	62		$	771
Less:
Labor costs within selling and administrative and research and development expenses		(111	)		—		(8	)		(119	)
Material purchases		(98	)		—		(17	)		(115	)
Labor costs within product and service cost of revenues		(75	)		—		(2	)		(77	)
Other segment expenses		(146	)		—		(13	)		(159	)
Corporate and other expenses:
Corporate expenses										(88	)
Purchased intangibles amortization and purchase accounting fair value step-up expenses										(12	)
Stock-based compensation										(13	)

Total operating income	$	279		$	—	$	22		$	188

Operating Income %		39.4	%		—		35.2	%		24.4	%


	Six Months Ended July 4, 2026
	Analytical & Materials Sciences			Biosciences			Advanced Diagnostics			Total
Total revenues, net	$	1,442		$	600		$	870		$	2,912
Less:
Labor costs within selling and administrative and research and development expenses		(306	)		(96	)		(134	)		(536	)
Material purchases		(269	)		(90	)		(111	)		(470	)
Labor costs within product and service cost of revenues		(172	)		(71	)		(130	)		(373	)
Other segment expenses		(193	)		(134	)		(306	)		(633	)
Corporate and other expenses:
Corporate expenses											(339	)
Purchased intangibles amortization and purchase accounting fair value step-up expenses											(650	)
Stock-based compensation											(45	)

Total operating income	$	502		$	209		$	189		$	(134	)

Operating income %		34.8	%		34.8	%		21.7	%		(4.6	%)


	Six Months Ended June 28, 2025
	Analytical & Materials Sciences			Biosciences		Advanced Diagnostics			Total
Total revenues, net	$	1,318		$	—	$	115		$	1,433
Less:
Labor costs within selling and administrative and research and development expenses		(187	)		—		(15	)		(202	)
Material purchases		(186	)		—		(32	)		(218	)
Labor costs within product and service cost of revenues		(159	)		—		(3	)		(162	)
Other segment expenses		(290	)		—		(25	)		(315	)
Corporate and other expenses:
Corporate expenses										(146	)
Purchased intangibles amortization and purchase accounting fair value step-up expenses										(24	)
Stock-based compensation										(26	)

Total operating income	$	496		$	—	$	40		$	340

Operating Income %		37.6	%		—		34.6	%		23.7	%